Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
TUI AG

Start price
Target price
Perf. (%)
€4.86
€7.00
-3.17%

Could be worthwhile Investment >10% per year
Fair valuation
Strong uniques
Differentiated customer and product portfolio
buy
Carnival plc

Start price
Target price
Perf. (%)
€18.10
-
-0.55%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
GlaxoSmithKline plc

Start price
Target price
Perf. (%)
€14.65
€17.30
-2.85%

Could be very worthwhile Investment >20% year
High dividend yield expected
Good rating
Small Risks for its business
buy
Unilever plc

Start price
Target price
Perf. (%)
€45.28
€60.00
-2.32%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
positive Cash Flow expected
buy
Rio Tinto plc

Start price
Target price
Perf. (%)
€63.61
€72.00
16.88%

Could be worthwhile Investment >10% per year
Medium risks for its business
Market Leader or Top 3
Sustainability is little important
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€87.23
€95.00
-8.48%

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
buy
TUI AG

Start price
Target price
Perf. (%)
€4.49
€10.00
4.65%

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Carnival plc

Start price
Target price
Perf. (%)
€14.95
-
20.40%

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
Significant cyclical dependencies
buy
Royal Dutch Shell A

Start price
Target price
Perf. (%)
€15.50
€18.00
12.51%

Could be worthwhile Investment >10% per year
High dividend yield expected
ROE higher than 10% per year
Revenue decline/stagnation expected
buy
Royal Dutch Shell A

Start price
Target price
Perf. (%)
€14.86
-
17.34%

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
Revenue decline/stagnation expected
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.36
€90.00
-4.23%

Could be worthwhile Investment >10% per year
Higher risks for its business
buy
TUI AG

Start price
Target price
Perf. (%)
€4.64
€6.00
1.34%

Market Leader or Top 3
Well known brand
High challenges to pay loans and raise capital
Very high cyclical dependencies
buy
Carnival plc

Start price
Target price
Perf. (%)
€12.76
€28.00
41.07%

EBIT growth >5% per year expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Bad rating
buy
Vodafone Group

Start price
Target price
Perf. (%)
€1.22
-
19.70%

AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
€78.00
-15.07%

buy
Royal Dutch Shell A

Start price
Target price
Perf. (%)
€11.72
€21.00
49.97%

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
€105.50
-16.31%

Future proof or reliable business model
Small cyclical dependencies
Known brand
buy
Royal Dutch Shell A

Start price
Target price
Perf. (%)
€14.75
€15.00
21.11%

Could be worthwhile Investment >10% per year
buy
British American Tobacco PLC

Start price
Target price
Perf. (%)
€28.13
€53.00
22.47%

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Very capable Management
Very good company culture
buy
Lloyds Banking Group

Start price
Target price
Perf. (%)
€0.73
€1.00
-25.07%